. . . . . . . "[Significantly, pharmacological blockade of the ?(2A)AR by a clinically used antagonist reduces AD-related pathology and ameliorates cognitive deficits in an AD transgenic model, suggesting that repurposing clinical ?(2A)R antagonists would be an effective therapeutic strategy for AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:18+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .